Company Filing History:
Years Active: 2017
Title: Lars Petter Jordheim: Innovator in Cancer Treatment
Introduction
Lars Petter Jordheim is a notable inventor based in Saint-Priest, France. He has made significant contributions to the field of cancer treatment through his innovative research and development of therapeutic compounds.
Latest Patents
Jordheim holds a patent for "5'-nucleotidase inhibitors and therapeutic uses thereof." This invention involves compounds with a 6-aminopurine backbone, which are designed for use in the treatment of cancer. The patent outlines specific structural formulas and therapeutic applications that could potentially enhance cancer treatment options.
Career Highlights
Throughout his career, Lars Petter Jordheim has worked with esteemed organizations such as the Centre National De La Recherche Scientifique and Hospices Civils De Lyon. His work in these institutions has allowed him to advance his research and contribute to significant medical advancements.
Collaborations
Jordheim has collaborated with notable colleagues, including Laurent Chaloin and Suzanne Peyrottes. These partnerships have fostered a collaborative environment that enhances innovation and research in the field of cancer therapeutics.
Conclusion
Lars Petter Jordheim's contributions to cancer treatment through his patented inventions and collaborative efforts highlight his role as a significant innovator in the medical field. His work continues to inspire advancements in therapeutic applications for cancer.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.